This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitè De Genève. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Margaux Heritier - Innovator in Cancer Treatment
Introduction
Margaux Heritier is an accomplished inventor based in Genève, Switzerland. She is affiliated with the University of Geneva, where she contributes to innovative research in the field of cancer treatment. Her work focuses on developing new therapeutic agents that can enhance the efficacy of immunotherapy.
Latest Patent Applications
Margaux Heritier has submitted a patent application titled "Adenosine 2A Receptor Modulators for Use in the Treatment of Cancer." This invention relates to new agents that are useful in treating cancers, particularly through immunotherapy. The application also includes pharmaceutically acceptable salts of these agents. Specifically, this invention provides new A2AR modulators, pharmaceutical compositions, and their uses.
Conclusion
Margaux Heritier is making significant strides in the field of cancer treatment through her innovative research and patent applications. Her contributions have the potential to impact the future of immunotherapy significantly.